Dr Reddys Laboratories (RDY) Revenue (2012 - 2026)

Dr Reddys Laboratories' Revenue history runs 15 years deep, the most recent figure standing at $963.2 million for Q1 2026.

• In Q1 2026, Revenue fell 1.94% year-over-year to $963.2 million; the TTM figure through Mar 2026 stood at $3.9 billion (up 1.94% YoY), while the FY2026 annual figure was $3.6 billion, down 6.06% from the prior year.
• Revenue was $963.2 million for Q1 2026 at Dr Reddys Laboratories, down from $980.0 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $998.5 million in Q2 2025 to a low of $641.0 million in Q1 2022.
• Historically, Revenue has averaged $871.4 million across 5 years, with a median of $859.7 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Revenue decreased 3.32% in 2022, then climbed 26.52% in 2023.
• A 5-year view of Revenue shows it stood at $767.0 million in 2022, then advanced by 12.97% to $866.5 million in 2023, then increased by 14.25% to $990.0 million in 2024, then dropped by 1.01% to $980.0 million in 2025, then decreased by 1.71% to $963.2 million in 2026.
• The last three Revenue figures came in at $963.2 million (Q1 2026), $980.0 million (Q4 2025), and $998.5 million (Q2 2025), per Business Quant data.